Armstrong Pharmaceuticals: Asthma Relief Soon to Revert to Rx-only Indication

Published: Mar 17, 2011

SILVER SPRING, Md., March 16, 2011 /PRNewswire-USNewswire/ -- The only over-the-counter asthma inhaler sold in the United States will no longer be available next year as part of an international agreement to stop the use of substances that damage the environment.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Learn more about why Primatene Mist is being discontinued and what asthma sufferers can do at

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm247196.htm

In Spanish

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm247377.htm

In Chinese

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm247378.htm

Sign up for e-mail notices of new FDA Consumer Updates at

https://service.govdelivery.com/service/subscribe.html?code=USFDA_9


View the FDA Consumer Update RSS feed at http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to consumerinfo@fda.hhs.gov.

Media Inquiries: Karen Riley at 301-796-4674; karen.riley@fda.hhs.gov

SOURCE U.S. Food and Drug Administration

Back to news